Delivery Order SPE2DB24D1201-SPE2DB25FJBQL

Award Date 2/20/25
Potential Completion Date 2/21/25
Potential Value $40K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $17,727.18 for the supply of NURTEC ODT 75 MG TABLET 8S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 6, 2023. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $12,718.61 for the provision of NURTEC ODT 75 MG TABLET 8S. The contract, awarded by the Defense Logistics Agency (DLA), has an ultimate completion date of December 3, 2024 and utilizes a Firm Fixed Price pricing type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $5,344.41 awarded by the Defense Logistics Agency (DLA). The contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a period of performance running through January 5, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order contract valued at $25,162.44 for the supply of NURTEC ODT 75 MG TABLET 8S. The contract has an ultimate completion date of June 5, 2024 and was awarded on June 4, 2022 by the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $23,665.33 for the supply of NURTEC ODT 75 MG TABLET 8S. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 26, 2023. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply NURTEC ODT 75 MG TABLET 8S to the Defense Logistics Agency (DLA). The award, valued at $9,758.02, is a Firm Fixed Price Delivery Order that will run through November 4, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp is a $59,095.53 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for NURTEC ODT 75 MG TABLET 8S. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order (DO) valued at $3,231.46 for the supply of NURTEC ODT 75 MG TABLET 8S. The contract is issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 22, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,115.72 firm fixed-price delivery order contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $22,751.89 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on August 1, 2024. The contract has a firm fixed price and an ultimate completion date of August 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB25FJBQL
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $40,295.68 for the supply of NURTEC ODT 75 MG TABLET 8S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 21, 2025. The contract is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. This contract award is part of the company's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/22/25, 8:32 PM